RPRX - Royalty Pharma plc

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 27.97

Open

$ 28.59

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 27.88 - $ 28.78

52 Week Range

$ 25.54 - $ 34.14

Volume

5,005,222

Average Volume

Market Cap

16.71B

Beta (5Y Monthly)

$ 0.63

PE Ratio (TTM)

$ 20.92

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.03)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-15-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	02-15-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-15-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-11-2021	06-30-2021	10-Q
13	05-11-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-12-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Royalty Pharma To Acquire Royalties And Mi...
05/09/2024 11:20:42

Under the terms of ImmuNext's licensing agreement with Sanofi, ImmuNext is entitled to receive an upward tiering net royalt...

Royalty Pharma Sees FY24 Portfolio Receipt...
05/09/2024 11:05:34

Royalty Pharma Q1 Sales $568.00M Miss $663...
05/09/2024 11:02:34

Royalty Pharma (NASDAQ:RPRX) reported quarterly sales of $568.00 million which missed the analyst consensus estimate of $663.22...

amgen-reports-better-than-expected-q1-results-50m-milestone-payment

Amgen Reports Better-Than-Expected Q1 Resu...
05/02/2024 21:44:40

Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company s...

Arrowhead Pharmaceuticals Earns $50M Miles...
05/02/2024 20:39:45

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced a $50 million milestone payment was received from Royalty Pharma ...

B of A Securities Maintains Buy on Royalty...
04/12/2024 12:01:57

B of A Securities analyst Geoff Meacham maintains Royalty Pharma (NASDAQ:RPRX) with a Buy and lowers the price target from $...

looking-into-royalty-pharmas-recent-short-interest

Looking Into Royalty Pharma's Recent Short...
04/04/2024 15:15:24

Royalty Pharma Q4 Sales $596.00M Miss $673...
02/15/2024 12:34:58

Royalty Pharma (NASDAQ:RPRX) reported quarterly sales of $596.00 million which missed the analyst consensus estimate of $673.65...

Earnings Scheduled For February 15, 2024
02/15/2024 10:17:01

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

Royalty Pharma's Earnings: A Preview
02/14/2024 14:00:50

CORRECTION: Royalty Pharma Announces Quart...
01/19/2024 13:23:03

Royalty Pharma Announces Quarterly Dividen...
01/19/2024 13:16:54

Reflecting a 5% increase in the company's quarterly dividend over the previous quarter's dividend. Reflecting a 5% incr...

Watching MSCI Inc.; Spruce Point Capital M...
01/17/2024 14:39:41

NOTE TO EDITORS: The Following is an Investment Opinion Issued by Spruce Point Capital ManagementProvides Evidence That Each of...

Royalty Pharma Expects To Deliver Portfoli...
01/08/2024 12:35:37

Teva And Royalty Pharma Announce Collabora...
11/13/2023 13:12:13

Morgan Stanley Maintains Overweight on Roy...
11/09/2023 14:37:43

Morgan Stanley analyst Terence Flynn maintains Royalty Pharma (NASDAQ:RPRX) with a Overweight and raises the price target fr...

Royalty Pharma Sees FY23 Adj. Cash Receipt...
11/08/2023 12:04:16

Royalty Pharma Q3 2023 EPS Adj. Cash Recei...
11/08/2023 12:03:45

Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Royalty Pharma's Earnings Outlook
11/07/2023 14:01:01